Robert A. Weinberg
24Patents
10h-index
22Co-inventors
75Inventor score
Filing activity: Oct 1, 1982 → Aug 1, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4935341A | Detection of point mutations in neu genes | Emerging Cross-Sectional Technologies | 79 | Expired |
| US4740463A | Methods and artificial genes for antagonizing the function of an oncogene | Human Necessities | 76 | Expired |
| US4535058A | Characterization of oncogenes and assays based thereon | Emerging Cross-Sectional Technologies | 74 | Expired |
| US4786718A | Method of preparing antibodies to characterize oncogenes | Emerging Cross-Sectional Technologies | 55 | Expired |
| US5604107A | Detection of neu p185 in cell lysates | Emerging Cross-Sectional Technologies | 53 | Expired |
| US8568998B2 | Methods of diagnosing, preventing and treating cancer metastasis | Chemistry; Metallurgy | 40 | Active |
| US6001969A | Recombinant TGF-.beta. type II receptor polypeptides | Human Necessities | 19 | Expired |
| US6008011A | TGF-.beta. type II receptor cDNAs | Human Necessities | 17 | Expired |
| US8252591B2 | Hormone responsive tissue culture system and uses thereof | Chemistry; Metallurgy | 14 | Active |
| US6046157A | Modulation of TGF-.beta. by recombinant TGF-.beta. type II receptor polypeptides | Human Necessities | 12 | Expired |
| US6201108A | TGF-.beta. type receptor cDNAs encoded products and uses therefor | Human Necessities | 7 | Expired |
| US6010872A | Recombinant production of TGF-.beta. type III receptor (betaglycan) polypeptides | Human Necessities | 6 | Expired |
| US7491530B2 | Fusion partner cells and uses thereof | Chemistry; Metallurgy | 5 | Expired |
| US5300631A | Antibodies specific for either ras photo-oncogene encoded P21 proteins or ras oncogene encoded P21 proteins but not for both and method of producing same | Emerging Cross-Sectional Technologies | 5 | Expired |
| US8936939B2 | Hormone responsive tissue culture system and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US9308238B2 | Compositions and methods for modulating EMT and uses thereof | Human Necessities | 3 | Active |
| US6713619B1 | Oncogenes and methods for their detection | Chemistry; Metallurgy | 3 | Expired |
| US6086867A | Modulation of TGF-.beta. by TGF-.beta. type III receptor polypeptides | Human Necessities | 2 | Expired |
| US6861511B1 | Detection and quantification of neu related proteins in the biological fluids of humans | Chemistry; Metallurgy | 0 | Expired |
| US11530385B2 | Hormone responsive tissue culture system and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10106778B2 | Selective targeting of cancer stem cells | Chemistry; Metallurgy | 0 | Active |
| US8088590B2 | Use of FOXC2 in diagnosing, preventing and treating cancer metastasis | Chemistry; Metallurgy | 0 | Active |
| US10398672B2 | Methods and compositions for targeting cancer stem cells | Emerging Cross-Sectional Technologies | 0 | Active |
| US9212347B2 | Progenitor cells and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.